Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0075 | 0.8512 | 0.8512 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Brugia malayi | hypothetical protein | 0.0067 | 0.7404 | 0.6243 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.9669 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.3091 | 0.3091 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0086 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Onchocerca volvulus | 0.0067 | 0.7404 | 0.5 | |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.3091 | 0.3091 |
Echinococcus multilocularis | jun protein | 0.0086 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.3091 | 0.3996 |
Echinococcus granulosus | jun protein | 0.0086 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.7736 | 1 |
Schistosoma mansoni | jun-related protein | 0.007 | 0.7736 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0086 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.3091 | 0.5 |
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0075 | 0.8512 | 0.8512 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.3091 | 0.3996 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.